Please login to the form below

Not currently logged in
Email:
Password:

PharmaLex expands with new Paris office

Sophie Guillaume and Patrick Larcier to lead the new branch

PharmaLexPharmaceutical service provider PharmaLex has expanded its European operations with the launch of a new office in Paris, France.

The firm, which merged with YES Pharma Services in October last year, will now offer its pharmacovigilance and regulatory affairs consulting expertise to the French pharmaceutical industry and looks to grow its local presence in the area.

Dr Thomas Dobmeyer, co-chief executive officer of PharmaLex, said: “For the pharmaceutical industry, France plays a significant role on an international level.

“It is of great importance and strategic interest to be able to service this highly thriving market.”

Leading the new subsidiary are Sophie Guillaume and Patrick Larcier, as general manager and senior director for drug development and vigilance, respectively.

Guillaume commented: “Together with Patrick Larcier, I am excited to have planted the seed for PharmaLex in France.

“We will grow our local presence in close cooperation with our international colleagues, allowing us to provide highest standards of quality of all services from the very beginning.”

Article by
Rebecca Clifford

10th October 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics